Barclays’s Genelux GNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding GNLX
Barclays's GNLX Position: Q3 2026 in Review
Barclays reduced its Genelux (GNLX) stake by 91% in Q3 2026, selling an estimated $656 and leaving 25 shares worth $63. The position accounts for ﹤0.01% of the portfolio, ranked #5071.
Barclays first reported a position in GNLX in Q1 2023 and has held it in 10 quarters since. The position peaked at $920K in Q1 2023. 34 funds tracked by Wall St. Rank hold GNLX as of Q3 2026.
- Barclays held 25 shares of Genelux worth $63 as of Q3 2026.
- Barclays sold 241 Genelux shares in Q3 2026, an estimated $656.
- Genelux made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5071 holding.
- Barclays first reported a position in Genelux in Q1 2023 and has held it in 10 quarters since.
- Barclays's Genelux position peaked at $920K in Q1 2023.
- 34 funds tracked by Wall St. Rank held Genelux as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.